UT/Erlanger Oncology & Hematology
Welcome,         Profile    Billing    Logout  
 3 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Graham, Robert M
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC).

Completed
3
298
Europe, Canada, US, RoW
NovoTTF-200M device, Best Standard of Care
NovoCure GmbH
Brain Metastases from Non-small Cell Lung Cancer (NSCLC)
11/24
11/24
NCT01191151: Web Based Orthopaedic Sports Medicine Registry

Terminated
N/A
12500
Europe, Canada, US, RoW
Arthrex, Inc.
Degenerative and Traumatic Pathology of the Knee, Degenerative and Traumatic Pathology of the Shoulder and Elbow, Degenerative and Traumatic Pathology of the Foot and Ankle, Degenerative and Traumatic Pathology of the Hand and Wrist, Degenerative and Traumatic Pathology of the Hip
07/23
07/23
TRIDENT, NCT04471844: Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant with RT & TMZ for the Treatment of Newly Diagnosed GBM

Active, not recruiting
N/A
982
Europe, Canada, Japan, US, RoW
Optune®
NovoCure Ltd.
Glioblastoma Multiforme
01/26
01/26
SCAD, NCT04496687: International Spontaneous Coronary Artery Dissection () "i" Registry

Recruiting
N/A
1000
US, RoW
SCAD Alliance, PERFUSE Study Group
Spontaneous Coronary Artery Dissection
12/25
12/25
Department, Research
SAPPHIRE, NCT05156320 / 2021-005314-34: Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

Active, not recruiting
3
188
Europe, US
Apitegromab, SRK-015, Placebo
Scholar Rock, Inc.
Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, SMA, Neuromuscular Diseases, Muscular Atrophy, Atrophy, Muscular Atrophy, Spinal, Neuromuscular Manifestations, Anti-myostatin
10/24
12/24
REPAIR-MDS, NCT04997811: Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes

Recruiting
2
120
Europe
Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol
Prof. Janet Dunn, Blood Cancer UK, Dudley Group NHS Foundation Trust, University of Birmingham, University of Manchester, King's College Hospital NHS Trust
Myelodysplastic Syndromes (MDS)
01/25
06/25
NCT04901806 / 2021-001029-32: Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

Terminated
1
29
Europe, US, RoW
PBI-200
Pyramid Biosciences, Pyramid Biosciences, Inc., Pyramid Biosciences
Solid Tumor, Adult, Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor
07/23
07/23
DOLCE, NCT05389774: Determining the Impact of Optellum's Lung Cancer Prediction Solution

Recruiting
N/A
2000
Europe
Nottingham University Hospitals NHS Trust, Optellum Ltd.
AI (Artificial Intelligence), Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple, Lung Cancer
01/25
01/25
NCT05202808: RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study

Active, not recruiting
N/A
500
US
Light Adjustable lens (LAL) and Light Delivery Device (LDD), Control IOL
RxSight, Inc.
Aphakia, Cataract
09/24
12/24
NCT03737149: A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform

Active, not recruiting
N/A
10500
Europe, US, RoW
mymobility with Apple Watch
Zimmer Biomet
Osteoarthritis, Knee, Osteoarthritis, Hip
12/24
07/25
NCT05294432: Validation of the Pain Relief Measure

Recruiting
N/A
100
Canada
Wilderman Medical Clinic
Chronic Pain
08/22
03/23
Nagireddy, Sumana
No trials found
Metcalf, Jill
No trials found
Cowart, Erica
No trials found

Download Options